Editor's Correspondence |

Treatment of Delirium Tremens

Nicole C. Bouchard, MD; Andrew Meltzer, MD; Robert S. Hoffman, MD
Arch Intern Med. 2005;165(5):587. doi:10.1001/archinte.165.5.587-a.
Text Size: A A A
Published online


We would like to commend Mayo-Smith et al1 for their attempt to define practice guidelines for delirium tremens, a potentially lethal and commonly mistreated condition. We are concerned, however, that the authors do not clearly recommend intravenous benzodiazepines as the sedative-hypnotic of choice despite sound pharmacological rationale. The alcohol withdrawal results from reduced inhibition from GABAA receptors and excitation from glutamate (N-methyl-D-aspartate) receptors. Benzodiazepines, barbiturates, and other GABAergic agents are effective, probably owing to cross-tolerance with ethanol at the GABAA receptor.2 The use of titrated intravenous benzodiazepines usually leads to rapid control of these critically ill patients. Furthermore, we believe that the use of β-blockers, clonidine, and neuroleptics merely reduces the sympathetic symptoms of inadequately sedated patients without treating the underlying cause or improving outcome. In addition, experimental and clinical evidence contraindicate neuroleptics.2,3 Treatment protocols that emphasize loading doses of diazepam and symptom-triggered treatment, along with continuous monitoring, lead to a more rapid and safe detoxification.4,5

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles